Halozyme Therapeutics, Inc.

Mirae Asset Global Investments Co., Ltd. HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

5,714

Value ($000)

385

Weight

0.0%

2020 Q3 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	385	0.0%	5,714	12/31/2025
2025 Q3	11/3/2025	380	0.0%	5,177	9/30/2025
2025 Q2	7/21/2025	248	0.0%	4,760	6/30/2025
2025 Q1	4/24/2025	263	0.0%	4,121	3/31/2025
2024 Q4	1/27/2025	204	0.0%	4,240	12/31/2024
2024 Q3	10/23/2024	261	0.0%	4,582	9/30/2024
2024 Q2	7/30/2024	196	0.0%	3,800	6/30/2024
2024 Q1	5/1/2024	2,915	0.0%	78,664	3/31/2024
2023 Q4	1/24/2024	2,826	0.0%	76,472	12/31/2023
2023 Q3	10/26/2023	2,895	0.0%	75,798	9/30/2023
2023 Q2	8/10/2023	2,645	0.0%	73,659	6/30/2023
2023 Q1	5/4/2023	2,971	0.0%	77,789	3/31/2023
2022 Q4	2/9/2023	3,733	0.0%	65,606	12/31/2022
2022 Q3	11/10/2022	2,591	0.0%	65,529	9/30/2022
2022 Q2	8/15/2022	2,169	0.0%	49,283	6/30/2022
2021 Q3	11/15/2021	339	0.0%	8,322	9/30/2021
2021 Q2	8/11/2021	329	0.0%	7,241	6/30/2021
2021 Q1	5/13/2021	307	0.0%	7,364	3/31/2021
2020 Q4	2/10/2021	384	0.0%	8,979	12/31/2020
2020 Q3	11/12/2020	224	0.0%	8,512	9/30/2020